Immune checkpoint inhibitors, such as programmed cell death 1 (PD-1)/program death-ligand 1 (PD-L1) inhibitors and cytotoxic T-lymphocyte antigen 4 (CTLA-4) destroy tumor cells through T-cell-mediated mechanisms by reversing immune escape or evasion. The gene discussed is PDCD1; the disease is neoplasm.